N/A (SANOFICONR)
Healthcare | Drug Manufacturers - General
₹4985.8
0.62% (₹30.6)
Market Overview
| Market Cap | 114825961472 |
| Volume | 26001 |
| 52W High | ₹5375.0 |
| 52W Low | ₹4211.55 |
Key Ratios
| P/E Ratio | 63.279602 |
| EPS | 78.79 |
| Beta | 0 |
| Dividend Yield | 1.11% |
Financial Performance
Revenue Growth
-0.653%
Profit Margin
0.24983%
ROE
0.75323%
ROA
0.42825%
Stock Analysis Score: 60/100
Growth Score: 60/100
Key Strengths:
- Excellent profit margins above 15%
- Strong ROE above 15%
- Low volatility with beta below 1
- Strong operating margins above 15%
Recommendation
Buy - The stock shows good fundamentals with some room for improvement
Detailed Analysis
Growth: -0.7% revenue growth indicates weak business expansion.
Profitability: 25.0% profit margin shows excellent operational efficiency.
Returns: ROE of 75.3% demonstrates strong return on shareholder investment.
Valuation: PE ratio of 63.3x is expensive compared to market averages.
Trading Decision Guide
- Score 80-100: Consider for long-term investment with high conviction
- Score 60-79: Suitable for medium-term investment with regular monitoring
- Score 40-59: Short-term trading opportunities, maintain strict stop-losses
- Score Below 40: High-risk trading only, thorough research essential
Risk Factors
- Market Cap: ₹11482.6Cr
- Beta: 0.00 (Market Volatility)
- 52-Week Range: ₹4211.6 - ₹5375.0
Last Updated: 2025-04-16 19:25:12